Business Description
CalciMedica Inc
NAICS : 541714
SIC : 2834
ISIN : US38942Q2021
Share Class Description:
CALC: Ordinary SharesDescription
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.56 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 50.3 | |||||
| 3-Year EPS without NRI Growth Rate | 51.5 | |||||
| 3-Year FCF Growth Rate | 56.5 | |||||
| 3-Year Book Growth Rate | -71.8 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 42.65 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 45.53 | |||||
| 9-Day RSI | 39.95 | |||||
| 14-Day RSI | 38.95 | |||||
| 3-1 Month Momentum % | -16.07 | |||||
| 6-1 Month Momentum % | -49.11 | |||||
| 12-1 Month Momentum % | -43.11 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.15 | |||||
| Quick Ratio | 4.15 | |||||
| Cash Ratio | 3.86 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -56.6 | |||||
| Shareholder Yield % | -66.57 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -112.43 | |||||
| ROA % | -73.51 | |||||
| ROIC % | -3815.47 | |||||
| 3-Year ROIIC % | 304.06 | |||||
| ROC (Joel Greenblatt) % | -11950.32 | |||||
| ROCE % | -127.34 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.7 | |||||
| Price-to-Tangible-Book | 2.7 | |||||
| EV-to-EBIT | 0.5 | |||||
| EV-to-EBITDA | 0.5 | |||||
| EV-to-FCF | 0.47 | |||||
| Price-to-Net-Current-Asset-Value | 2.87 | |||||
| Price-to-Net-Cash | 3.29 | |||||
| Earnings Yield (Greenblatt) % | 200 | |||||
| FCF Yield % | -64.65 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CALC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CalciMedica Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.08 | ||
| Beta | 0.58 | ||
| 3-Year Sharpe Ratio | -0.11 | ||
| 3-Year Sortino Ratio | -0.24 | ||
| Volatility % | 65.46 | ||
| 14-Day RSI | 38.95 | ||
| 14-Day ATR ($) | 0.244062 | ||
| 20-Day SMA ($) | 2.45275 | ||
| 12-1 Month Momentum % | -43.11 | ||
| 52-Week Range ($) | 1.86 - 6.265 | ||
| Shares Outstanding (Mil) | 13.48 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CalciMedica Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CalciMedica Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
CalciMedica Inc Frequently Asked Questions
What is CalciMedica Inc(CALC)'s stock price today?
The current price of CALC is $2.27. The 52 week high of CALC is $6.27 and 52 week low is $1.86.
When is next earnings date of CalciMedica Inc(CALC)?
The next earnings date of CalciMedica Inc(CALC) is 2025-05-13 Est..
Does CalciMedica Inc(CALC) pay dividends? If so, how much?
CalciMedica Inc(CALC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers